Search Results - Scott J Rodig
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma by Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Published in Blood Advances (2017-12-01)Get full text
Article -
2
-
3
A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma by Nageatte Ibrahim, Elizabeth I. Buchbinder, Scott R. Granter, Scott J. Rodig, Anita Giobbie‐Hurder, Carla Becerra, Argyro Tsiaras, Evisa Gjini, David E. Fisher, F. Stephen Hodi
Published in Cancer Medicine (2016-11-01)Get full text
Article -
4
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients by Yves Boucher, Ashwin S. Kumar, Jessica M. Posada, Evisa Gjini, Kathleen Pfaff, Mikel Lipschitz, Ana Lako, Dan G. Duda, Scott J. Rodig, F. Stephen Hodi, Rakesh K. Jain
Published in npj Precision Oncology (2021-06-01)Get full text
Article -
5
Next-generation cDNA screening for oncogene and resistance phenotypes. by Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, Timothy J Sullivan, Oliver Weigert, Andrew A Lane, Nadja Kopp, Liat Bird, Scott J Rodig, Edward A Fox, David M Weinstock
Published in PLoS ONE (2012-01-01)Get full text
Article -
6
CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas by Linfeng Chen, Jing Ouyang, Kirsty Wienand, Kamil Bojarczuk, Yansheng Hao, Bjoern Chapuy, Donna Neuberg, Przemyslaw Juszczynski, Lee N. Lawton, Scott J. Rodig, Stefano Monti, Margaret A. Shipp
Published in Haematologica (2020-05-01)Get full text
Article -
7
RelA-Induced Interferon Response Negatively Regulates Proliferation. by Bose S Kochupurakkal, Zhigang C Wang, Tony Hua, Aedin C Culhane, Scott J Rodig, Koraljka Rajkovic-Molek, Jean-Bernard Lazaro, Andrea L Richardson, Debajit K Biswas, J Dirk Iglehart
Published in PLoS ONE (2015-01-01)Get full text
Article -
8
Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish by Evisa Gjini, Chang-Bin Jing, Ashley T. Nguyen, Deepak Reyon, Emma Gans, Michiel Kesarsing, Joshua Peterson, Olga Pozdnyakova, Scott J. Rodig, Marc R. Mansour, Keith Joung, A. Thomas Look
Published in Disease Models & Mechanisms (2019-05-01)Get full text
Article -
9
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma by Jeffrey A. Barnes, Eric Jacobsen, Yang Feng, Arnold Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson
Published in Haematologica (2013-04-01)Get full text
Article -
10
Graph neural network modeling of spatial tumor-immune interactions identifies prognostic cellular niches in non‑small cell lung cancer by Katharina V. Hoebel, James R. Lindsay, Jennifer Altreuter, Joao V. Alessi, Jason L. Weirather, Ian Dryg, Anita Giobbie-Hurder, Zhirou Li, Kun-Hsing Yu, Mark M. Awad, Scott J. Rodig, William Lotter
Published in npj Precision Oncology (2026-03-01)Get full text
Article -
11
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies by Mara M. Epstein, Bernard Rosner, Elizabeth C. Breen, Julie L. Batista, Edward L. Giovannucci, Larry Magpantay, Jon C. Aster, Scott J. Rodig, Kimberly A. Bertrand, Francine Laden, Otoniel Martínez-Maza, Brenda M. Birmann
Published in Haematologica (2018-10-01)Get full text
Article -
12
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy by Stefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, Outi Kilpivaara, Kristen Stevenson, Donna Neuberg, Mignon L Loh, Wen-Shu Wu, Scott J Rodig, Guillermo Garcia-Manero, Hagop M Kantarjian, A Thomas Look
Published in eLife (2013-07-01)Get full text
Article -
13
MAPS: pathologist-level cell type annotation from tissue images through machine learning by Muhammad Shaban, Yunhao Bai, Huaying Qiu, Shulin Mao, Jason Yeung, Yao Yu Yeo, Vignesh Shanmugam, Han Chen, Bokai Zhu, Jason L. Weirather, Garry P. Nolan, Margaret A. Shipp, Scott J. Rodig, Sizun Jiang, Faisal Mahmood
Published in Nature Communications (2024-01-01)Get full text
Article -
14
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities by Elizabeth A. Morgan, M. Patrick Sweeney, Tamiwe Tomoka, Nadja Kopp, Daniel Gusenleitner, Robert A. Redd, Christopher D. Carey, Leo Masamba, Steve Kamiza, Geraldine S. Pinkus, Donna S. Neuberg, Scott J. Rodig, Danny A. Milner, Jr, David M. Weinstock
Published in Blood Advances (2016-11-01)Get full text
Article -
15
192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma by Mizuki Nishino, Biagio Ricciuti, Scott J Rodig, Joao V Alessi, Jia Luo, Mark M Awad, Bruce E Johnson, Federica Pecci, Alessandro Di Federico, Malini M Gandhi, Lynette M Sholl, Maisam Makarem, Emma Voligny, Tom Nguyen, Danielle Haradon
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
16
Graph Fourier transform for spatial omics representation and analyses of complex organs by Yuzhou Chang, Jixin Liu, Yi Jiang, Anjun Ma, Yao Yu Yeo, Qi Guo, Megan McNutt, Jordan E. Krull, Scott J. Rodig, Dan H. Barouch, Garry P. Nolan, Dong Xu, Sizun Jiang, Zihai Li, Bingqiang Liu, Qin Ma
Published in Nature Communications (2024-08-01)Get full text
Article -
17
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC by Joao V. Alessi, Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Arielle Elkrief, Scott J. Rodig, Emily S. Lebow, Jordan E. Eicholz, Maria Thor, Andreas Rimner, Adam J. Schoenfeld, Jamie E. Chaft, Bruce E. Johnson, Daniel R. Gomez, Mark M. Awad, Narek Shaverdian
Published in Nature Communications (2023-07-01)Get full text
Article -
18
Circulating cytokine associations with clinical outcomes in melanoma patients treated with combination nivolumab plus ipilimumab by Jiajia Chen, Giuseppe Tarantino, Mariano Severgnini, Joanna Baginska, Anita Giobbie-Hurder, Jason L. Weirather, Michael Manos, Janice D. Russell, Kathleen L. Pfaff, Scott J. Rodig, Amy Y. Huang, Ryan Brennick, Matthew Nazzaro, Emma Hathaway, Marta Holovatska, Claire Manuszak, Srinika Ranasinghe, David Liu, F. Stephen Hodi
Published in OncoImmunology (2025-12-01)Get full text
Article -
19
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma by Michael J. Dennis, Dean C. Pavlick, Alec Kacew, Michael Wotman, Laura E. MacConaill, Stephanie M. Jones, Kathleen L. Pfaff, Scott J. Rodig, Stephen Eacker, Maika Malig, Emily Reister, David Piccioni, Santosh Kesari, Kartik Sehgal, Robert I. Haddad, Ezra Cohen, Marshall R. Posner, Ida Deichaite, Glenn J. Hanna
Published in Journal of Translational Medicine (2024-10-01)Get full text
Article -
20
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas by Scott J. Rodig, Jeffery L. Kutok, Jennifer C. Paterson, Hiroaki Nitta, Wenjun Zhang, Bjoern Chapuy, Lynette K. Tumwine, Santiago Montes-Moreno, Claudio Agostinelli, Nathalie A. Johnson, Susana Ben-Neriah, Pedro Farinha, Margaret A. Shipp, Miguel A. Piris, Thomas M. Grogan, Stefano A. Pileri, Randy D. Gascoyne, Teresa Marafioti
Published in Haematologica (2010-12-01)Get full text
Article
